Title Page | Introduction | Principles
of Intraperitoneal Chemotherapy | Current Indications for
Cytoreductive Surgery and Intraperitoneal Chemotherapy
Heated
Intraoperative Intraperitoneal Chemotherapy by the Coliseum
Technique
Immediate
Postoperative Abdominal Lavage in Preparation for Early
Postoperative Intraperitoneal 5-Fluorouracil
Early
Postoperative Intraperitoneal Chemotherapy for Adenocarcinoma | Induction
Intraperitoneal Chemotherapy for Debilitating Ascites
Cytoreductive
Surgery for Peritoneal Surgacy Malignancy - Pertitonectomy
Procedures | Results of Treatment of
Peritoneal Surface Malignancy
Conclusions | References
V. | EARLY POSTOPERATIVE INTRAPERITONEAL CHEMOTHERAPY FOR ADENOCARCINOMA |
Intraperitoneal chemotherapy following complete cytoreduction
in patients with appendiceal, colonic, rectal, gastric, or other
gastrointestinal adenocarcinomas has utilized early postoperative
intraperitoneal 5-fluorouracil. In pretreated ovarian cancer
patients who have neurologic toxicities from systemic cisplatin,
additional cisplatin should not be used. These patients are also
treated with 5-fluorouracil.
The standardized orders for early postoperative administration of
intraperitoneal 5-fluorouracil are shown in Table 7.
TABLE 7 |
Early postoperative intraperitoneal chemotherapy with 5-fluorouracil |
Postoperative Days 1-5
|
Title Page | Introduction | Principles
of Intraperitoneal Chemotherapy | Current Indications for
Cytoreductive Surgery and Intraperitoneal Chemotherapy
Heated
Intraoperative Intraperitoneal Chemotherapy by the Coliseum
Technique
Immediate
Postoperative Abdominal Lavage in Preparation for Early
Postoperative Intraperitoneal 5-Fluorouracil
Early
Postoperative Intraperitoneal Chemotherapy for Adenocarcinoma | Induction
Intraperitoneal Chemotherapy for Debilitating Ascites
Cytoreductive
Surgery for Peritoneal Surgacy Malignancy - Pertitonectomy
Procedures | Results of Treatment of
Peritoneal Surface Malignancy
Conclusions | References